Pharmafile Logo
Pharmafocus logo
Advanced Search

Pfizer’s Sutent receives conditional EMEA approval

August 3, 2006
Sales and Marketing

 Pfizer's new kidney cancer drug Sutent is rapidly catching up with its recently approved rival, Bayer's Nexavar.Sutent (sunitinib) has been …

News

Crestor leads AZ European sales growth

August 3, 2006
Sales and Marketing

Crestor was AstraZeneca's most rapidly expanding product in terms of European sales in the second quarter of this year.  Sales …

News

Pfizer’s smoking-cessation drug a step closer to European approval

August 3, 2006
Sales and Marketing

Pfizer's potential blockbuster smoking cessation drug Champix has been recommended for European approval by a key EMEA committee.The first-in-class treatment …

News

Study boost for AstraZeneca’s Nexium

August 1, 2006
Sales and Marketing

AstraZeneca's blockbuster gastro-oesophageal reflux disease treatment Nexium has come out ahead of Wyeth's Zoton in a new study, which showed …

News

MDS named top clinical research company in Europe

August 1, 2006
Research and Development

MDS Pharma Services has been named Europe's best provider of clinical research services in a survey of trial investigators.Conducted by …

News

First cervical cancer vaccine close to European approval

August 1, 2006
Sales and Marketing

The first-ever cervical cancer vaccine is set for approval in Europe following its recommendation from a key advisory committee.The positive …

News

Market Research…..our survey said

July 31, 2006
Sales and Marketing market research

Marrying traditional techniquesDespite researchers' natural leaning towards either qualitative or quantitative research, it is clear that the two types of …

Feature

New organisation to advise on patients’ medicines leaflet

July 28, 2006
Medical Communications

A new organisation has been set up to give the medicines regulatory agency independent advice on how to improve patient …

News

New NHS Chief Executive appointed

July 28, 2006

David Nicholson, the current head of the health service in London has been named as the new NHS chief executive.With …

News

Wyeth looks for European boost from Enbrel NICE guidance

July 27, 2006
Sales and Marketing

Wyeth's Enbrel has received a dual recommendation from NICE – guidance the pharma company hopes will influence healthcare decisions elsewhere …

News

Nexavar gets EU go-ahead in advanced kidney cancer

July 27, 2006
Sales and Marketing

Bayer has received the green light from European regulators for Nexavar to treat the most common type of kidney cancer …

News

NICE boost for Taxotere

July 27, 2006

Sanofi-Aventis breast cancer treatment Taxotere has been recommended by NICE in early breast cancer, giving it a boost over a …

News

NICE Herceptin appeal decision expected in weeks

July 27, 2006

A final decision from NICE on Roche's breast cancer treatment Herceptin is expected within five weeks, following a PCT appeal …

News

Significant reduction in animal extremist attacks

July 27, 2006

The number of attacks by animal rights extremists in the first six months of 2006 dropped sharply, building on improvements …

News

Aurora to raise European allergy awareness for UCB Pharma

July 26, 2006
Medical Communications

Healthcare communications agency Aurora has won a pan-European account to promote UCB Pharma's non-sedating prescription antihistamine Xyzal.The agency, based in …

News

Tighter safeguards proposed for high-risk clinical trials

July 26, 2006
Research and Development

The expert group set up by the MHRA in the wake of the disastrous Northwick Park clinical trial has made …

News

Novartis speeds up Tasigna programme

July 25, 2006
Sales and Marketing

Novartis' new cancer drug will be submitted earlier than expected for European and US approval after showing positive results in …

News

Are you ready to become an interim manager?

July 25, 2006
Business Services interim management, recruitment

The last few years have seen both dramatic and rapid changes in the adoption of interim management in the life …

Feature

Use your intelligence to watch the competition

July 25, 2006
Research and Development, Sales and Marketing market research

One of the reasons the executives of ill-fated US energy group Enron were for a while 'the smartest guys in …

Feature

NHS allergy services criticised

July 21, 2006

People with allergies often feel let down by NHS services with patient groups expected to make up shortfalls, according to …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026